Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.79 USD | -0.62% | +1.10% | +13.81% |
Mar. 14 | Barrington Ups Price Target on Anika Therapeutics to $37 From $29, Keeps Outperform Rating | MT |
Mar. 13 | Transcript : Anika Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.81% | 378M | |
-2.86% | 87.37B | |
+4.08% | 41.01B | |
-25.35% | 28.08B | |
+54.12% | 24.72B | |
-4.52% | 17.47B | |
-42.09% | 11.69B | |
-17.77% | 11.6B | |
-12.10% | 11.56B | |
+0.75% | 8.44B |
- Stock Market
- Equities
- ANIK Stock
- News Anika Therapeutics, Inc.
- Sector Update: Health Care Stocks Gain Premarket Friday